Top Healthcare Stocks
Healthcare stocks were higher with the NYSE Healthcare Sector
Index rising about 0.3%.
In company news, Receptos (
) shares were set to finish with strong gains Tuesday after the
drug-maker reported positive results from Phase II testing of its
RPC1063 drug candidate to treat multiple-sclerosis drug.
The company said the experimental drug met its primary endpoint
of reducing MRI brain lesion activity in patients with relapsing
multiple sclerosis. The overall safety profile was consistent with
the results of prior trials and continues to support the
differentiation of RPC1068 against other oral agents now on the
market or in clinical development.
RCPT shares last traded at $39.44 each, earlier climbing to a
session high of $40.94 a share. The stock has a 52-week range of
$15.21 to $55.00 a share, rising 106% over that 12-month span.
In other sector news,
(+) ACHN, FDA lifts clinical hold on sovaprevir, allowing the
drug-maker to conduct trials on the prospective hepatitis C
treatment. The drug was well-tolerated during two previous Phase II
trials, ACHN said.
(-) VRX, Allergan (
) again rejects sweetened, $53 bln buyout offer, with Valient and
Pershing Square Management raising their bid another 15% to $72 a
share in cash and 0.83 of a VRX share - or $177.10 a share,
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.